Article
Pharmacogenetics of antipsychotic-induced side effects.
Dialogues in clinical neuroscience - 1 Jan 2009
Lencz Todd, Malhotra Anil K
Abstract excerpt
Currently available antipsychotic drugs (APDs) carry significant though highly variable, liability to neurologic and metabolic side effects. Pharmacogenetics approaches offer the possibility of identifying patient-specific biomarkers for predicting risk of these side effects. To date, a few single nucleotide polymorphisms (SNPs) in a handful of genes have received convergent support across multiple studies. The...
Topics
Join the communities discussing this publication.